SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-209916
Filing Date
2019-08-01
Accepted
2019-08-01 09:01:50
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d777824d10q.htm 10-Q 645002
2 EX-10.1 d777824dex101.htm EX-10.1 7190
3 EX-10.2 d777824dex102.htm EX-10.2 7359
4 EX-31.1 d777824dex311.htm EX-31.1 10119
5 EX-31.2 d777824dex312.htm EX-31.2 10099
6 EX-32.1 d777824dex321.htm EX-32.1 5245
13 GRAPHIC g777824g38e44.jpg GRAPHIC 3025
  Complete submission text file 0001193125-19-209916.txt   3949045

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aqxp-20190630.xml EX-101.INS 1053290
8 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20190630.xsd EX-101.SCH 27392
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20190630_cal.xml EX-101.CAL 31065
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20190630_def.xml EX-101.DEF 67901
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20190630_lab.xml EX-101.LAB 229160
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20190630_pre.xml EX-101.PRE 179279
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 19991222
SIC: 2834 Pharmaceutical Preparations